Should You Hold Homology Medicines Inc (FIXX) Stock Tuesday Morning?

Tuesday, June 13, 2023 09:03 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Hold Homology Medicines Inc (FIXX) Stock Tuesday Morning?

Homology Medicines Inc (FIXX) has fallen Tuesday morning, with the stock declining -10.71% in pre-market trading to 1. FIXX's short-term technical score of 12 indicates that the stock has traded less bullishly over the last month than 88% of stocks on the market. In the Biotechnology industry, which ranks 82 out of 146 industries, FIXX ranks higher than 16% of stocks. Homology Medicines Inc has risen 14.29% over the past month, closing at $1.05 on May 16. During this period of time, the stock fell as low as $0.97 and as high as $1.14. FIXX has an average analyst recommendation of Strong Buy. The company has an average price target of $8.43.

FIXX has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on FIXX!

See Full FIXX Report

Homology Medicines Inc has a Long-Term Technical rank of 29. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 71% of the market scoring higher. In the Biotechnology industry which is number 81 by this metric, FIXX ranks better than 81% of stocks.

Important Dates for Investors in FIXX:

-Homology Medicines Inc is set to release earnings on 8/9/2023. Over the last 12 months, the company has reported EPS of $-2.18. -We do not have a set dividend date for Homology Medicines Inc at this time. Click Here To Get The Full Report on Homology Medicines Inc (FIXX)